title: [Occurrence of hepatocellular carcinoma in patients with chronic hepatitis C who continued to be HCV-RNA negative for up to 3 years by interferon].
authors.affiliation: Department of Internal Medicine, Kitasato Institute Hospital.
authors.forename: N
authors.initials: N
authors.lastname: Miyao
authors.forename: H
authors.initials: H
authors.lastname: Serizawa
authors.forename: N
authors.initials: N
authors.lastname: Kumagai
authors.forename: H
authors.initials: H
authors.lastname: Takaishi
authors.forename: N
authors.initials: N
authors.lastname: Watanabe
authors.forename: Y
authors.initials: Y
authors.lastname: Hamada
authors.forename: K
authors.initials: K
authors.lastname: Tsuchimoto
authors.forename: O
authors.initials: O
authors.lastname: Takeuchi
authors.forename: H
authors.initials: H
authors.lastname: Toyoda
authors.forename: S
authors.initials: S
authors.lastname: Kuramochi
authors.forename: H
authors.initials: H
authors.lastname: Ishii
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins